Pituitary deficiency after aneurysmal subarachnoid hemorrhage

OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patient...

Full description

Bibliographic Details
Main Authors: Julio Leonardo Barbosa Pereira, Lucas Alverne Freitas de Albuquerque, Marcos Dellaretti, Gervásio Teles Cardoso de Carvalho, Gerival Vieira Jr, Vitor Michelstaedter Brochado, Austen Venâncio Drummond, Joyce Espeschit de Morais, Leticia Maia Ferreira, Paulo Augusto Carvalho Miranda, Atos Alves de Sousa
Format: Article
Language:English
Published: Faculdade de Medicina / USP 2013-06-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745
id doaj-506edf7d794148828a86d5b3ac853a22
record_format Article
spelling doaj-506edf7d794148828a86d5b3ac853a222020-11-24T22:24:33ZengFaculdade de Medicina / USPClinics1807-59321980-53222013-06-01686745749Pituitary deficiency after aneurysmal subarachnoid hemorrhageJulio Leonardo Barbosa PereiraLucas Alverne Freitas de AlbuquerqueMarcos DellarettiGervásio Teles Cardoso de CarvalhoGerival Vieira JrVitor Michelstaedter BrochadoAusten Venâncio DrummondJoyce Espeschit de MoraisLeticia Maia FerreiraPaulo Augusto Carvalho MirandaAtos Alves de SousaOBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation &#177;6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score &#8804;13 (t test, p&#8202;=&#8202;0.008), Hunt-Hess grade &#8805;4 (t test, p<0.001), or Fisher grade 4 (t test, p&#8202;=&#8202;0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745Subarachnoid HemorrhageEndocrine DysfunctionAneurysm
collection DOAJ
language English
format Article
sources DOAJ
author Julio Leonardo Barbosa Pereira
Lucas Alverne Freitas de Albuquerque
Marcos Dellaretti
Gervásio Teles Cardoso de Carvalho
Gerival Vieira Jr
Vitor Michelstaedter Brochado
Austen Venâncio Drummond
Joyce Espeschit de Morais
Leticia Maia Ferreira
Paulo Augusto Carvalho Miranda
Atos Alves de Sousa
spellingShingle Julio Leonardo Barbosa Pereira
Lucas Alverne Freitas de Albuquerque
Marcos Dellaretti
Gervásio Teles Cardoso de Carvalho
Gerival Vieira Jr
Vitor Michelstaedter Brochado
Austen Venâncio Drummond
Joyce Espeschit de Morais
Leticia Maia Ferreira
Paulo Augusto Carvalho Miranda
Atos Alves de Sousa
Pituitary deficiency after aneurysmal subarachnoid hemorrhage
Clinics
Subarachnoid Hemorrhage
Endocrine Dysfunction
Aneurysm
author_facet Julio Leonardo Barbosa Pereira
Lucas Alverne Freitas de Albuquerque
Marcos Dellaretti
Gervásio Teles Cardoso de Carvalho
Gerival Vieira Jr
Vitor Michelstaedter Brochado
Austen Venâncio Drummond
Joyce Espeschit de Morais
Leticia Maia Ferreira
Paulo Augusto Carvalho Miranda
Atos Alves de Sousa
author_sort Julio Leonardo Barbosa Pereira
title Pituitary deficiency after aneurysmal subarachnoid hemorrhage
title_short Pituitary deficiency after aneurysmal subarachnoid hemorrhage
title_full Pituitary deficiency after aneurysmal subarachnoid hemorrhage
title_fullStr Pituitary deficiency after aneurysmal subarachnoid hemorrhage
title_full_unstemmed Pituitary deficiency after aneurysmal subarachnoid hemorrhage
title_sort pituitary deficiency after aneurysmal subarachnoid hemorrhage
publisher Faculdade de Medicina / USP
series Clinics
issn 1807-5932
1980-5322
publishDate 2013-06-01
description OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation &#177;6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score &#8804;13 (t test, p&#8202;=&#8202;0.008), Hunt-Hess grade &#8805;4 (t test, p<0.001), or Fisher grade 4 (t test, p&#8202;=&#8202;0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome.
topic Subarachnoid Hemorrhage
Endocrine Dysfunction
Aneurysm
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745
work_keys_str_mv AT julioleonardobarbosapereira pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT lucasalvernefreitasdealbuquerque pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT marcosdellaretti pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT gervasiotelescardosodecarvalho pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT gerivalvieirajr pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT vitormichelstaedterbrochado pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT austenvenanciodrummond pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT joyceespeschitdemorais pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT leticiamaiaferreira pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT pauloaugustocarvalhomiranda pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
AT atosalvesdesousa pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage
_version_ 1725760738318876672